TAG:
laboratories
Pathology Groups Respond to Eroding Finances
By R. Lewis Dark | From the Volume XXI No. 4 – March 17, 2014 Issue
THESE ARE NOT THE BEST OF TIMES FOR ANATOMIC PATHOLOGY GROUPS. The various Medicare fee cuts enacted in the past couple of years have eroded the financial stability of a substantial number of the nation’s 3,300 independent pathology practices and laboratories. The consequences of eroding finances …
New Mass Spectrometry Toxicology Test Delivers Clinical Benefits
By Joseph Burns | From the Volume XXI No. 3 – February 24, 2014 Issue
CEO SUMMARY: Researchers at the University of Colorado in Aurora used mass spectrometry technology to create a paradigm-shifting toxicology test. It uses a urine specimen and can identify 112 compounds and more than 500 illicit and brand-name drugs in a single assay. For pain management t…
February 24, 2014 “Intelligence: Late Breaking Lab News”
By Robert Michel | From the Volume XXI No. 3 – February 24, 2014 Issue
Maybe the tough financial environment here in the United States is causing Sonic Healthcare Ltd., one of this nation’s bigger lab players, to be more interested in overseas lab testing opportunities. On February 18, its CEO, Colin Goldschmidt, M.D., told investors that “We contin…
Federal Judge Rules Against Idaho Hospital in Antitrust Case
By Robert Michel | From the Volume XXI No. 3 – February 24, 2014 Issue
LAST MONTH, A FEDERAL JUDGE RULED that St. Luke’s Health System of Boise, Idaho, violated antitrust laws when, in 2012, it acquired Saltzer Medical Group, the largest independent medical practice in the state. In ruling against the merger of a hospital and physici…
Federal Judge Lets Trial Proceed in Case against Quest
By Joseph Burns | From the Volume XXI No. 3 – February 24, 2014 Issue
CEO SUMMARY: Four California labs have charged that Quest Diagnostics engaged in predatory pricing in a case filed originally in November 2012. After the lawsuit was amended last summer and fall, U.S. District Judge William H. Orrick III heard various motions in the case. On February 6 he…
Labs, Path Groups Face Major Financial Issues
By Robert Michel | From the Volume XXI No. 3 – February 24, 2014 Issue
CEO SUMMARY: Are clinical labs and pathology groups ready for the end of fee-for-service reimbursement? That’s just one important question that will be answered at the upcoming Executive War College on Lab and Pathology Management that will take place in New Orleans on April 29-30. The …
Caris Life Sciences Achieves Accreditation to ISO 15189
By Robert Michel | From the Volume XXI No. 3 – February 24, 2014 Issue
IN DECIDING TO PURSUE ACCREDITATION TO ISO 15189: Medical Laboratories, Caris Life Sciences considered the international benefits of this designation. It was December when Caris Life Sciences of Irving, Texas, announced that it had earned accreditation to ISO 15189 from the …
Medicare OPPS Rule Has Pitfalls for Labs
By Joseph Burns | From the Volume XXI No. 2 – February 3, 2014 Issue
CEO SUMMARY: On January 1, the new Medicare rule for requiring bundled or packaged reimbursement for certain services covered by the hospital Outpatient Prospective Payment System (OPPS) became effective. Just four days earlier (on December 27), Medicare officials issued instructions on h…
Lean Used to Lay Groundwork for Lab’s 15189 Accreditation
By Joseph Burns | From the Volume XXI No. 2 – February 3, 2014 Issue
CEO SUMMARY: Henry Ford Health System’s laboratory organization has become first in the nation to have all its laboratory sites “standardized under one source of leadership” and accredited to the standards of ISO 15189: Medical Laboratories. The journey to achieve this current state…
Once Again, Revenue Declines at Quest Diagnostics Incorporated
By Robert Michel | From the Volume XXI No. 2 – February 3, 2014 Issue
FIRST TO REPORT its fourth quarter and full year earnings for 2013 was Quest Diagnostics Incorporated. It more than other potential buyers to released its earnings report last Thursday. For fourth quarter 2013, Quest Diagnostics generated revenue of $1.76 billion, c…
CURRENT ISSUE

Volume XXXII, No. 13 – September 15, 2025
The Dark Report examines a new bill that would reform PAMA and avoid reimbursement rate cuts scheduled for January 2026. Clinical laboratory leaders are urged to make their voices heard in Congress. Also, an expert describes how labs can fix pre-analytical errors and avoid disaster.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.
Topics
- Anatomic Pathology
- Clinical Chemistry
- Clinical Laboratory
- Clinical Laboratory Trends
- Digital Pathology
- Genetic Testing
- In Vitro Diagnostics
- IVD/Lab Informatics
- Lab Intelligence
- Lab Marketplace
- Lab Risk & Compliance
- Laboratory Automation
- Laboratory Billing
- Laboratory Compliance
- Laboratory Equipment
- Laboratory Information Systems
- Laboratory Management
- Lean Six Sigma
- Managed Care Contracts
- Molecular Diagnostics
- Pathology Trends
- People
- Uncategorized